The unique structure of haemophilus influenzae protein E reveals multiple binding sites for host factors

Infection and Immunity

Volumn 81, Issue 3, 2013, Pages 801-814

  Singh, Birendra ^a   Al Jubair, Tamim ^a   Mörgelin, Matthias ^b   Thunnissen, Marjolein M ^c   Riesbeck, Kristian ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; CYSTATIN; HAEMOPHILUS INFLUENZAE PROTEIN E; HOST FACTOR; LAMININ; UNCLASSIFIED DRUG; VITRONECTIN;

ALPHA HELIX; ANIMAL EXPERIMENT; ARTICLE; BETA SHEET; BINDING SITE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIMERIZATION; ELECTRON MICROSCOPY; HAEMOPHILUS INFLUENZAE; HYDROGEN BOND; LISTERIA MONOCYTOGENES; MOUSE; NONHUMAN; PASTEURELLACEAE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL PROTEINS; BINDING SITES; GENE EXPRESSION REGULATION, BACTERIAL; HAEMOPHILUS INFLUENZAE; MICE; MICE, INBRED BALB C; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROTEIN BINDING; PROTEIN CONFORMATION;

EID: 84874751330     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01111-12     Document Type: Article

References (43)

1. Murphy TF, Faden H, Bakaletz LO, Kyd JM, Forsgren A, Campos J, Virji M, Pelton SI. 2009. Nontypeable Haemophilus influenzae as a pathogen in children. Pediatr. Infect. Dis. J. 28:43-48.
2. van Wessel K, Rodenburg GD, Veenhoven RH, Spanjaard L, van der Ende A, Sanders EA. 2011. Nontypeable Haemophilus influenzae invasive disease in The Netherlands: a retrospective surveillance study 2001-2008. Clin. Infect. Dis. 53:e1-e7. doi:10.1093/cid/cir268.
3. Resman F, Ristovski M, Ahl J, Forsgren A, Gilsdorf JR, Jasir A, Kaijser B, Kronvall G, Riesbeck K. 2011. Invasive disease caused by Haemophilus influenzae in Sweden 1997-2009; evidence of increasing incidence and clinical burden of non-type b strains. Clin. Microbiol. Infect. 17:1638-1645.
4. Rubach MP, Bender JM, Mottice S, Hanson K, Weng HY, Korgenski K, Daly JA, Pavia AT. 2011. Increasing incidence of invasive Haemophilus influenzae disease in adults, Utah, USA. Emerg. Infect. Dis. 17: 1645-1650.
5. Grandi G. 2001. Antibacterial vaccine design using genomics and proteomics. Trends Biotechnol. 19:181-188.
6. Giufre M, Carattoli A, Cardines R, Mastrantonio P, Cerquetti M. 2008. Variation in expression of HMW1 and HMW2 adhesins in invasive nontypeable Haemophilus influenzae isolates. BMC Microbiol. 8:83.
7. Jurcisek JA, Bookwalter JE, Baker BD, Fernandez S, Novotny LA, Munson RS, Jr, Bakaletz LO. 2007. The PilA protein of non-typeable Haemophilus influenzae plays a role in biofilm formation, adherence to epithelial cells and colonization of the mammalian upper respiratory tract. Mol. Microbiol. 65:1288-1299.
8. Chang A, Kaur R, Michel LV, Casey JR, Pichichero M. 2011. Haemophilus influenzae vaccine candidate outer membrane protein P6 is not conserved in all strains. Hum. Vaccin. 7:102-105.
9. Dicko A, Odusanya OO, Diallo AI, Santara G, Barry A, Dolo A, Diallo A, Kuyinu YA, Kehinde OA, Francois N, Borys D, Yarzabal JP, Moreira M, Schuerman L. 2011. Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial. BMC Public Health 11:882.
10. Prymula R, Kriz P, Kaliskova E, Pascal T, Poolman J, Schuerman L. 2009. Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age. Vaccine 28:71-78.
11. Murphy TF. 2009. Current and future prospects for a vaccine for nontypeable Haemophilus influenzae. Curr. Infect. Dis. Rep. 11:177-182.
12. Ronander E, Brant M, Eriksson E, Morgelin M, Hallgren O, Westergren-Thorsson G, Forsgren A, Riesbeck K. 2009. Nontypeable Haemophilus influenzae adhesin protein E: characterization and biological activity. J. Infect. Dis. 199:522-531.
13. Singh B, Brant M, Kilian M, Hallstrom B, Riesbeck K. 2010. Protein E of Haemophilus influenzae is a ubiquitous highly conserved adhesin. J. Infect. Dis. 201:414-419.
14. Singh B, Su YC, Riesbeck K. 2010. Vitronectin in bacterial pathogenesis: a host protein used in complement escape and cellular invasion. Mol. Microbiol. 78:545-560.
15. Singh B, Fleury C, Jalalvand F, Riesbeck K. 2012. Human pathogens utilize host extracellular matrix proteins laminin and collagen for adhesion and invasion of the host. FEMS Microbiol. Rev. 36:1122-1180.
16. Hallstrom T, Blom AM, Zipfel PF, Riesbeck K. 2009. Nontypeable Haemophilus influenzae protein E binds vitronectin and is important for serum resistance. J. Immunol. 183:2593-2601.
17. Singh B, Jalalvand F, Morgelin M, Zipfel P, Blom AM, Riesbeck K. 2011. Haemophilus influenzae protein E recognizes the C-terminal domain of vitronectin and modulates the membrane attack complex. Mol. Microbiol. 81:80-98.
18. Hallstrom T, Singh B, Resman F, Blom AM, Morgelin M, Riesbeck K. 2011. Haemophilus influenzae protein E binds to the extracellular matrix by concurrently interacting with laminin and vitronectin. J. Infect. Dis. 204:1065-1074.
19. Barthel D, Singh B, Riesbeck K, Zipfel PF. 2012. Haemophilus influenzae uses the surface protein E to acquire human plasminogen and to evade innate immunity. J. Immunol. 188:379-385.
20. Singh B, Al Jubair T, Fornvik K, Thunnissen MM, Riesbeck K. 2012. Crystallization and X-ray diffraction analysis of a novel surface-adhesin protein: protein E from Haemophilus influenzae. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 68:222-226.
21. Kabsch W. 2010. XDS. Acta Crystallogr. D Biol. Crystallogr. 66:125-132.
22. Pape T, Schneider TR. 2004. HKL2MAP: a graphical user interface for phasing with SHELX programs. J. Appl. Crystallogr. 37:843-844. 23. Sheldrick GM. 2008. A short history of SHELX. Acta Crystallogr. A 64: 112-122.
23. Sheldrick GM. 2008. A short history of SHELX. Acta Crystallogr. A 64: 112-122.
24. Vonrhein C, Blanc E, Roversi P, Bricogne G. 2007. Automated structure solution with autoSHARP. Methods Mol. Biol. 364:215-230.
25. Langer G, Cohen SX, Lamzin VS, Perrakis A. 2008. Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7. Nat. Protoc. 3:1171-1179.
26. Emsley P, Lohkamp B, Scott WG, Cowtan K. 2010. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66:486-501.
27. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. 2010. PHENIX: a comprehensive Pythonbased system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66:213-221.
28. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. 2007. Phaser crystallographic software. J. Appl. Crystallogr. 40: 658-674.
29. Engel J, Furthmayr H. 1987. Electron microscopy and other physical methods for the characterization of extracellular matrix components: laminin, fibronectin, collagen IV, collagen VI, and proteoglycans. Methods Enzymol. 145:3-78.
30. Krissinel E, Henrick K. 2007. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372:774-797.
31. Soto GE, Hultgren SJ. 1999. Bacterial adhesins: common themes and variations in architecture and assembly. J. Bacteriol. 181:1059-1071.
32. Kuhnert P, Christensen H. (ed). 2008. Pasteurellaceae: biology, genomics and molecular aspects. Caister Academic Press, Norfolk, United Kingdom.
33. Holm L, Rosenstrom P. 2010. Dali server: conservation mapping in 3D. Nucleic Acids Res. 38:W545-W549.
34. Esposito V, Temussi PA. 2011. Cystatins: a versatile family. BioMol. Concepts 2:95-102.
35. de Castro E, Sigrist CJ, Gattiker A, Bulliard V, Langendijk-Genevaux PS, Gasteiger E, Bairoch A, Hulo N. 2006. ScanProsite: detection of PROSITE signature matches and ProRule-associated functional and structural residues in proteins. Nucleic Acids Res. 34:W362-W365.
36. Hayashi S, Wu HC. 1990. Lipoproteins in bacteria. J. Bioenerg. Biomembr. 22:451-471.
37. Nakayama H, Kurokawa K, Lee BL. 2012. Lipoproteins in bacteria: structures and biosynthetic pathways. FEBS. J. 279:4247-4268.
38. Johnson S, Tan L, van der Veen S, Caesar J, Goicoechea De Jorge E, Harding RJ, Bai X, Exley RM, Ward PN, Ruivo N, Trivedi K, Cumber E, Jones R, Newham L, Staunton D, Ufret-Vincenty R, Borrow R, Pickering MC, Lea SM, Tang CM. 2012. Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules. PLoS Pathog. 8:e1002981. doi:10.1371/journal.ppat.1002981.
39. Bergmann S, Lang A, Rohde M, Agarwal V, Rennemeier C, Grashoff C, Preissner KT, Hammerschmidt S. 2009. Integrin-linked kinase is required for vitronectin-mediated internalization of Streptococcus pneumoniae by host cells. J. Cell Sci. 122:256-267.
40. Bujacz G, Miller M, Harrison R, Thanki N, Gilliland GL, Ogata CM, Kim SH, Wlodawer A. 1997. Structure of monellin refined to 2.3 A resolution in the orthorhombic crystal form. Acta Crystallogr. D Biol. Crystallogr. 53:713-719.
41. Esposito V, Guglielmi F, Martin SR, Pauwels K, Pastore A, Piccoli R, Temussi PA. 2010. Aggregation mechanisms of cystatins: a comparative study of monellin and oryzacystatin. Biochemistry 49:2805-2810. 42. Corpet F. 1988. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 16:10881-10890.
42. Corpet F. 1988. Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res. 16:10881-10890.
43. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28:2731-2739.